Rhenman & Partners Asset Management AB / EW
Rhenman & Partners Asset Management AB’s Edwards Lifesciences Corp Position
Does Rhenman & Partners Asset Management AB own Edwards Lifesciences Corp (EW)? Yes — 163.0K shares worth $13M (+1.61% of its 13F portfolio) as of Q1 2026, down from 193.5K shares the prior filed quarter.
Position Value
$13M
Q1 2026
Shares
163.0K
% of Portfolio
+1.61%
Quarters Held
25
currently held
Position History EW
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 163.0K | $13M | +1.61% |
| Q4 2025 | 193.5K | $16M | +1.54% |
| Q3 2025 | 155.0K | $12M | +1.33% |
| Q2 2025 | 55.0K | $4M | +0.54% |
| Q2 2024 | 97.5K | $9M | +0.86% |
| Q3 2023 | 29.0K | $2M | +0.22% |
| Q2 2023 | 29.0K | $3M | +0.29% |
| Q1 2023 | 70.0K | $6M | +0.63% |
| Q4 2022 | 144.0K | $11M | +1.12% |
| Q3 2022 | 125.0K | $9M | +0.95% |
| Q2 2022 | 45.0K | $4M | +0.49% |
| Q1 2022 | 65.0K | $8M | +0.75% |
| Q4 2021 | 100.0K | $13M | +0.87% |
| Q3 2021 | 105.0K | $12M | +0.83% |
| Q2 2021 | 110.0K | $11M | +0.77% |
| Q1 2021 | 110.0K | $9M | +0.64% |
| Q4 2020 | 125.0K | $11M | +0.93% |
| Q3 2020 | 120.0K | $10M | +0.85% |
| Q2 2020 | 120.0K | $8M | +0.90% |
| Q1 2020 | 57.0K | $11M | +1.51% |
| Q4 2019 | 38.0K | $9M | +0.97% |
| Q3 2019 | 36.6K | $8M | +1.01% |
| Q2 2019 | 31.6K | $6M | +0.64% |
| Q1 2019 | 26.6K | $5M | +0.60% |
| Q4 2018 | 66.6K | $10M | +1.17% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rhenman & Partners Asset Management AB’s full portfolio or all institutional holders of EW.